Jan 042017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Surface Oncology, an immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced the appointment of industry leader Daniel S.… => Read more

Surface Oncology adds Dan Lynch to its Board of Directors as Executive Chairman

From:: Surface Oncology adds Dan Lynch to its Board of Directors as Executive Chairman

Sorry, the comment form is closed at this time.

%d bloggers like this: